What is the maximum dose of Haldol (Haloperidol)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2025 • View editorial policy

From the Guidelines

The maximum dose of Haldol (Haloperidol) is 10 mg daily for non-elderly patients and 5 mg daily for elderly patients when administered orally, as per the guidelines for managing delirium in the community 1.

Key Considerations

  • The dose can be increased in 0.5-1 mg increments as required, with a maximum daily dose of 10 mg for non-elderly patients and 5 mg for elderly patients 1.
  • For adolescents and adults, the maximum dose can be as high as 40 mg daily when administered intramuscularly (IM) or orally (PO) every 2 hours, but this is not recommended for elderly patients 2.
  • It's essential to consider the patient's age, weight, and severity of symptoms when determining the optimal dose of Haloperidol.

Administration Routes

  • Haloperidol can be administered orally, subcutaneously, or via intramuscular injection, with the same dose used for subcutaneous administration as for oral administration 1.
  • For severe cases, a subcutaneous infusion of 2.5-10 mg over 24 hours can be considered 1.

From the FDA Drug Label

DOSAGE AND ADMINISTRATION ... Daily dosages up to 100 mg may be necessary in some cases to achieve an optimal response. Infrequently, haloperidol has been used in doses above 100 mg for severely resistant patients; however, the limited clinical usage has not demonstrated the safety of prolonged administration of such doses The maximum dose of Haldol (Haloperidol) is up to 100 mg per day, but it has been used in doses above 100 mg in some cases for severely resistant patients, although the safety of such doses is not well established 3.

From the Research

Maximum Dose of Haldol (Haloperidol)

The maximum dose of Haldol (Haloperidol) is not explicitly stated in the provided studies. However, the studies suggest the following:

  • A study published in 2002 4 found that doses of haloperidol in the range of >3-7.5 mg/day had a lower rate of development of clinically significant extrapyramidal adverse effects than higher doses.
  • A study published in 2013 5 also found that doses of haloperidol in the range of >3-7.5 mg/day had a lower rate of development of clinically significant extrapyramidal adverse effects than higher doses.
  • Some key points to consider when determining the maximum dose of Haldol (Haloperidol) are:
    • The optimal dose of haloperidol for the treatment of a first episode of psychosis was found to be 2 mg daily for 15 subjects, 5 mg daily for 11, 10 mg daily for 7, and 20 mg daily for 3 in a study published in 1999 6.
    • A study published in 1998 7 found that clinical improvement is enhanced by increasing haloperidol concentration up to about 10 ng/ml, and a therapeutic window can be defined by a lower threshold level of about 5 ng/ml and an upper threshold of about 17 ng/ml.
    • A study published in 1991 8 found that dosages higher than 10 mg/d of haloperidol for most patients have no additional beneficial effect in the treatment of acute or exacerbated schizophrenia.
  • Some general considerations for the maximum dose of Haldol (Haloperidol) include:
    • The dose of haloperidol should be individualized based on the patient's response and tolerance 4, 5.
    • Higher doses of haloperidol may be associated with a higher risk of extrapyramidal adverse effects 4, 5.
    • The therapeutic window of haloperidol serum concentration is between 5 ng/ml and 17 ng/ml, with a maximum therapeutic effect at 10 ng/ml 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Haloperidol dose for the acute phase of schizophrenia.

The Cochrane database of systematic reviews, 2002

Research

Haloperidol dose for the acute phase of schizophrenia.

The Cochrane database of systematic reviews, 2013

Research

Optimal haloperidol dosage in first-episode psychosis.

Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1999

Research

Dosage of haloperidol for schizophrenia.

Archives of general psychiatry, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.